In our study, suppression of STAT3 activation by TSG-6 resulted in reduced hepatic steatosis and hepatic TG level, which was at odds with our assumption that STAT3 activation was localized within hepatocytes. This evidence concerns the gene TNFAIP6 and Hepatic steatosis.